Gottlieb Leaves FDA With Final Thought On What To Do About Cosmetics

Addressing for the last time the House Appropriations subcommittee with FDA oversight, Commissioner Scott Gottlieb shared his vision for sharpening cosmetics oversight in the absence of significant new resources.

FDA entrance sign 2016

FDA’s 23rd Commissioner Scott Gottlieb has returned to the American Enterprise Institute, a Washington-based public policy think tank, after two years at FDA’s helm.

As a resident fellow at AEI, a position he held previously at the nonprofit beginning in 2003, Gottlieb “continues his work on improving public health through entrepreneurship and medical innovation and on expanding regulatory approaches to maintain patient and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation